Group One Trading’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-200
| Closed | -$39.9K | – | 7814 |
|
|
2025
Q4 | $39.9K | Sell |
200
-5,900
| -97% | -$1.07M | ﹤0.01% | 5783 |
|
|
2025
Q3 | $954K | Sell |
6,100
-300
| -5% | -$47.6K | ﹤0.01% | 3087 |
|
|
2025
Q2 | $971K | Buy |
6,400
+4,400
| +220% | +$587K | ﹤0.01% | 2794 |
|
|
2025
Q1 | $301K | Buy |
+2,000
| New | +$335K | ﹤0.01% | 3578 |
|
|
2023
Q3 | – | Sell |
-6,200
| Closed | -$1.3M | – | 7730 |
|
|
2023
Q2 | $1.3M | Buy |
6,200
+5,400
| +675% | +$1.07M | ﹤0.01% | 2104 |
|
|
2023
Q1 | $161K | Buy |
800
+100
| +14% | +$22.7K | ﹤0.01% | 3865 |
|
|
2022
Q4 | $153K | Sell |
700
-19,000
| -96% | -$4.15M | ﹤0.01% | 4079 |
|
|
2022
Q3 | $3.88M | Buy |
19,700
+19,600
| +19,600% | +$4.23M | 0.01% | 1365 |
|
|
2022
Q2 | $21K | Hold |
100
| – | – | ﹤0.01% | 6244 |
|
|
2022
Q1 | $28K | Sell |
100
-6,100
| -98% | -$1.88M | ﹤0.01% | 6516 |
|
|
2021
Q4 | $2.34M | Sell |
6,200
-21,100
| -77% | -$8.2M | ﹤0.01% | 2426 |
|
|
2021
Q3 | $11.3M | Buy |
27,300
+400
| +1% | +$166K | 0.01% | 982 |
|
|
2021
Q2 | $9.95M | Sell |
26,900
-2,600
| -9% | -$868K | 0.01% | 1084 |
|
|
2021
Q1 | $8.55M | Buy |
29,500
+28,100
| +2,007% | +$7.81M | 0.01% | 1055 |
|
|
2020
Q4 | $350K | Sell |
1,400
-1,300
| -48% | -$310K | ﹤0.01% | 3592 |
|
|
2020
Q3 | $611K | Buy |
+2,700
| New | +$560K | ﹤0.01% | 2668 |
|
|
2020
Q1 | – | Sell |
-1,000
| Closed | -$153K | – | 5327 |
|
|
2019
Q4 | $153K | Buy |
+1,000
| New | +$138K | ﹤0.01% | 3351 |
|
|
2019
Q1 | – | Sell |
-11,400
| Closed | -$1.29M | – | 4884 |
|
|
2018
Q4 | $1.29M | Buy |
11,400
+900
| +9% | +$113K | 0.01% | 1324 |
|
|
2018
Q3 | $1.41M | Buy |
+10,500
| New | +$1.3M | 0.01% | 1425 |
|
|
2016
Q3 | – | Sell |
-3,600
| Closed | -$297K | – | 4586 |
|
|
2016
Q2 | $297K | Hold |
3,600
| – | – | ﹤0.01% | 2133 |
|
|
2016
Q1 | $273K | Buy |
3,600
+2,100
| +140% | +$155K | ﹤0.01% | 2115 |
|
|
2015
Q4 | $121K | Hold |
1,500
| – | – | ﹤0.01% | 2861 |
|
|
2015
Q3 | $95K | Buy |
+1,500
| New | +$108K | ﹤0.01% | 3071 |
|
|
2015
Q2 | – | Sell |
-4,000
| Closed | -$317K | – | 4892 |
|
|
2015
Q1 | $317K | Sell |
4,000
-4,000
| -50% | -$295K | 0.01% | 1983 |
|
|
2014
Q4 | $509K | Buy |
8,000
+7,400
| +1,233% | +$464K | 0.01% | 1550 |
|
|
2014
Q3 | $36K | Sell |
600
-4,000
| -87% | -$229K | ﹤0.01% | 3760 |
|
|
2014
Q2 | $246K | Sell |
4,600
-4,000
| -47% | -$219K | ﹤0.01% | 2217 |
|
|
2014
Q1 | $519K | Buy |
8,600
+5,500
| +177% | +$321K | 0.01% | 1618 |
|
|
2013
Q4 | $164K | Buy |
3,100
+2,300
| +288% | +$116K | ﹤0.01% | 2610 |
|
|
2013
Q3 | $37K | Sell |
800
-2,700
| -77% | -$124K | ﹤0.01% | 3761 |
|
|
2013
Q2 | $144K | Buy |
+3,500
| New | +$150K | ﹤0.01% | 2470 |
|
Other funds holding CRL
VCM
VPM
Group One Trading's CRL Position: Q1 2026 in Review
Group One Trading reduced its Charles River Laboratories (CRL) stake by 75% in Q1 2026, selling an estimated $40.8K and leaving 75 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6221.
Group One Trading first reported a position in CRL in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.61M in Q1 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Group One Trading held 75 shares of Charles River Laboratories worth $12.9K as of Q1 2026.
- Group One Trading sold 220 Charles River Laboratories shares in Q1 2026, an estimated $40.8K.
- Charles River Laboratories made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6221 holding.
- Group One Trading first reported a position in Charles River Laboratories in Q2 2013 and has held it in 23 quarters since.
- Group One Trading's Charles River Laboratories position peaked at $1.61M in Q1 2025.
- 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.